Latest News
-

Has a "wonder drug" for dementia been discovered? (Spoiler alert: no.)
⏱️ 8 min read
Media reports of a wonder drug for neurodegenerative diseases like Huntington's disease are overhyped
-

Huntington's Disease Therapeutics Conference 2017 – Day 3
⏱️ 5 min read
HDBuzz summarises final day of the 2017 Huntington's Disease Therapeutics Conference in Malta
-

Huntington's Disease Therapeutics Conference 2017 – Day 2
⏱️ 4 min read
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta – day 2
-

Huntington's Disease Therapeutics Conference 2017 – Day 1
⏱️ 6 min read
HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta – day 1
-

Enemy at the gates – huntingtin disrupts nuclear transport
⏱️ 7 min read
Two recent studies show how a cellular border control system goes wrong in HD, opening new avenues for HD research.
-

FDA approves a new drug for symptoms of Huntington's disease
⏱️ 4 min read
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
-

Sheep leading the flock: metabolism and biomarkers in HD
⏱️ 8 min read
Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.
-

Weeding out the truth: can cannabis improve Huntington’s?
⏱️ 8 min read
What can individual experiences with cannabis tell us about Huntington's disease?
-

Huntingtin grabs a hammer: DNA repair in HD
⏱️ 8 min read
Huntingtin helps fix damaged DNA, a recent study suggests, under the direction of a gene repair protein called ATM.
-

The benefits of migration, highlighted in Huntington's disease
⏱️ 6 min read
Is HD a developmental disease? HD stops neurons migrating in developing brain, but maybe we can get them going again
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
-
September 2026: This month in Huntington’s disease research
-
Studying Stutters: What 900,000 genomes teach us about growing DNA repeats
-
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
-
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
